Pharma Mirror

DECEMBER 1, 2021

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, sponsored a randomized, double-blind, placebo-controlled clinical trial that included 969. The post Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19 appeared first on Pharma Mirror Magazine.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Deltaclinical

JANUARY 13, 2023

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Scienmag

JANUARY 20, 2022

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5

Allergies 89

Allergies Trial Funding Clinical Trials Clinical Trials 89

Velocity Clinical Research

OCTOBER 21, 2024

At the beginning of September, Velocity Clinical Research topped Business North Carolina ’s 2024 Fast 40 list. For a clinical trials organization to achieve this level of scale is notable. Recruitment Clinical trial sites live and die by their ability to recruit patients into trials.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

Antidote

SEPTEMBER 1, 2023

As part of our efforts to better understand patients and their motivations to participate in clinical trials, Antidote and SCORR Marketing partnered on a survey to gain a deeper understanding of how patients think about the medical research process.

Clinical Trials 95

Clinical Trials Clinical Trials Trials Allergies 95

Clinical Trial Podcast

SEPTEMBER 26, 2022

To answer these two questions, regulatory authorities around the world require medical product manufacturers to conduct Phase I, also known as early phase clinical trials. The post Complexity in Early Phase Clinical Trials with Dr. The post Complexity in Early Phase Clinical Trials with Dr. Oren Cohen?

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

Scienmag

NOVEMBER 18, 2021

Louis and Massachusetts General Hospital/Harvard Medical School in Boston have received a seven-year, $22 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to help lead a multicenter clinical trial evaluating whether a novel immunosuppressant can […].

Clinical Trials 86

Clinical Trials Clinical Trials Trial Funding Trials 86

Medical Xpress

FEBRUARY 28, 2023

A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children.

Allergies 75

Allergies Clinical Trials Clinical Trials Medicine 75

Pharmaceutical Technology

SEPTEMBER 16, 2022

The latest conditional recommendation is based on the final data from the SOLIDARITY clinical trial, which was sponsored by the WHO. These results are in line with those obtained from the placebo-controlled, double-blind ACTT-1 trial of the National Institute of Allergy and Infectious Diseases.

Allergies 277

Allergies RNA Clinical Trials Clinical Trials 277

BioTech 365

OCTOBER 29, 2021

Global Peanut Allergy Clinical Trials Review, H2 2021 Report – ResearchAndMarkets.com Global Peanut Allergy Clinical Trials Review, H2 2021 Report – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Peanut Allergy – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s (..)

Allergies 40

Allergies Clinical Trials Clinical Trials Trials 40

Pharmaceutical Technology

JUNE 16, 2023

The Phase IIa trial (NCT05734040) in Australia will see a potential 500 volunteers given OVX836 in combination with quadrivalent influenza vaccines (QIVs). The developer has tested OVX836 in four completed clinical trials.

Vaccine 246

Vaccine Vaccination Trials Immune Response 246

World of DTC Marketing

OCTOBER 6, 2021

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, also provided Emory with more than $19 million in additional grants. As of December 2020, federal funding for preclinical studies and clinical trials involving remdesivir totaled about $162 million, as follows: $0.7

Clinical Trials 198

Clinical Trials Clinical Trials Allergies Trials 198

XTalks

NOVEMBER 6, 2020

Canadian clinical-stage biotech company Symvivo Corporation has developed an oral COVID-19 vaccine that entered clinical trials this week. The first healthy volunteer was dosed with the vaccine in Australia as part of the bacTRL-Spike COVID-19 Phase I clinical trial. COVID-19 Clinical Trials.

Clinical Trials 75

Clinical Trials Clinical Trials Vaccine Vaccination 75

Scienmag

APRIL 21, 2021

Credit: NIAID A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19. The therapeutic […].

Antibody 81

Antibody Clinical Trials Clinical Trials Trials 81

JAMA Internal Medicine

JULY 16, 2023

This randomized clinical trial aims to determine whether a direct oral penicillin challenge is noninferior to the standard of care of penicillin skin testing followed by an oral challenge in patients with a low-risk penicillin allergy.

Allergies 57

Allergies Clinical Trials Clinical Trials Trials 57

Rethinking Clinical Trials

NOVEMBER 29, 2022

The NIH Pragmatic Trials Collaboratory is excited to welcome the INSPIRE Demonstration Project to its portfolio of innovative, large-scale pragmatic clinical trials embedded in healthcare systems. Shruti Gohil. Dr. Susan Huang. Dr. Richard Platt. Huang and Platt are experienced investigators in the NIH Collaboratory.

Trials 130

Trials Clinical Trials Clinical Trials Allergies 130

Rethinking Clinical Trials

JANUARY 24, 2023

INSPIRE is supported within the NIH Pragmatic Trials Collaboratory by a grant from the National Institute of Allergy and Infectious Diseases (NIAID). The post January 24, 2023: INSPIRE Intervention Goes Live, Will Use Predictive Algorithm to Reduce Unnecessary Antibiotic Prescribing appeared first on Rethinking Clinical Trials.

Allergies 130

Allergies Clinical Trials Clinical Trials Trials 130

Medical Xpress

JANUARY 30, 2023

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

Vaccine 104

Vaccine Vaccination Immune Response Allergies 104

Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). This trial will evaluate the safety of the vaccine and generate efficacy data. Intravacc has received a contract worth $14.6m

Vaccine 147

Vaccine Vaccination Development Bacterium 147

NY Times

DECEMBER 18, 2020

Four people so far have had allergic reactions after getting the Pfizer-BioNTech vaccine. Experts say that shouldn’t deter most people from getting a jab.

Allergies 94

Allergies Vaccine Vaccination Clinical Trials 94

Scienmag

MAY 25, 2021

May 25, 2021 — Critical Path Institute (C-Path) today announced its schedule for the Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Considerations for Drug Development Workshop, to be held virtually June 15-16. Together […].

Clinical Trials 73

Clinical Trials Clinical Trials Trials Development 73

Medical Xpress

DECEMBER 22, 2022

The study analyzed data from two phase 3 clinical trials and involved an international group of researchers, including those from Children's Hospital of Philadelphia (CHOP).

Antibody 75

Antibody Allergies Clinical Trials Clinical Trials 75

Trialfacts

JANUARY 23, 2024

More Study Details About the Study A peanut allergy can be severe and life-threatening if not treated promptly. Peanut allergies are one of the most common food allergies in children in the USA, with more than 2% of children being affected. Participants will receive a new potential treatment for their peanut allergy at no cost.

Allergies 52

Allergies Research Doctors Doctor 52

Antidote

NOVEMBER 20, 2023

In both 2018 and 2023, Antidote partnered with SCORR marketing to conduct surveys intended to increase the understanding of patients’ perceptions of clinical trials. Our 2018 survey collected data from nearly 4,000 individuals to gain insight into what matters most when considering a clinical trial.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Allergies 52

pharmaphorum

AUGUST 5, 2020

DBV Technologies’ long and tortuous path to an FDA verdict on its Viaskin Peanut allergy shot has led to another dead end. DBV says it plans to request a meeting with the FDA to discuss its comments in the CRL as well, as that may be needed in another clinical trial to support another refiling. “We

Allergies 52

Allergies Production Clinical Trials Clinical Trials 52

VirTrial

JULY 7, 2024

In recent years, there has been significant activity in the AD clinical trial landscape, including the approval of novel systemic therapies. Accurate measurement of AD severity over time is crucial for evaluating treatment efficacy in these trials. The HOME Core outcome set for clinical trials of atopic dermatitis.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Dermatology 59

Scienmag

FEBRUARY 26, 2022

Peanut allergies are hard to treat and can cause fatal or near-fatal anaphylactic reactions. People usually don’t outgrow peanut allergy, requiring lifelong scrutiny of food labels to avoid even small traces of peanut.

Allergies 75

Allergies Clinical Trials Clinical Trials Trials 75

World of DTC Marketing

NOVEMBER 19, 2021

In 2015, the National Institute of Allergy and Infectious Diseases, an institute within the NIH, signed a cooperative R&D agreement with Moderna on basic research, including new vaccines. invested $20 billion in pharmaceutical companies to quickly move forward on clinical trials, development, and production capabilities.

Vaccine 44

Vaccine Vaccination Allergies Production 44

Pharmaceutical Technology

APRIL 26, 2023

There is also increasing data from large-scale randomised clinical trials demonstrating their impact on improving asthma outcomes,” says Dr. Giselle Mosnaim, clinical associate professor at the University of Chicago Pritzker School of Medicine.

Clinical Trials 289

Clinical Trials Clinical Trials Research Allergies 289

Pharmaceutical Technology

DECEMBER 7, 2022

Sanofi and Regeneron’s Dupixent had previously been linked to conjunctivitis, an eye condition usually caused by allergies or an infection. This symptom, captured previously in clinical trials for the drug, was typically mild, but it is known to worsen without proper management and care.

Production 162

Production Regulation Clinical Trials Clinical Trials 162

Medical Xpress

MARCH 6, 2023

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. A non-temperature stable form of the candidate previously had been tested in several clinical trials.

Immune Response 75

Immune Response Vaccine Vaccination Trials 75

Pharmaceutical Technology

JANUARY 8, 2023

With three votes for and 16 against, the US Pulmonary Allergy Drugs Advisory Committee refused its use as an add-on treatment to inhaled corticosteroid-based maintenance. There have been several attempts to introduce biologics into the COPD space. In 2018, the FDA rejected the approval application for GSK’s Nucala (mepolizumab) in COPD.

Antibody 298

Antibody Trials Clinical Trials Clinical Trials 298

VirTrial

JULY 7, 2024

In recent years, there has been significant activity in the AD clinical trial landscape, including the approval of novel systemic therapies. Accurate measurement of AD severity over time is crucial for evaluating treatment efficacy in these trials. The HOME Core outcome set for clinical trials of atopic dermatitis.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Dermatology 52

VirTrial

JULY 7, 2024

In recent years, there has been significant activity in the AD clinical trial landscape, including the approval of novel systemic therapies. Accurate measurement of AD severity over time is crucial for evaluating treatment efficacy in these trials. The HOME Core outcome set for clinical trials of atopic dermatitis.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Dermatology 52